Objective: In this study, the economic cost, diagnostic and prognostic laboratory markers of lumbar spondylodiscitis, which emerged as a complication after surgical intervention in the lumbar region, were investigated.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Objective: In this study, the economic cost, diagnostic and prognostic laboratory markers of lumbar spondylodiscitis, which emerged as a complication after surgical intervention in the lumbar region, were investigated.
📊
Key Findings & Data:Objective: In this study, the economic cost, diagnostic and prognostic laboratory markers of lumbar spondylodiscitis, which emerged as a complication after surgical intervention in the lumbar region, were investigated.
💡
Conclusion & Impact:Objective: In this study, the economic cost, diagnostic and prognostic laboratory markers of lumbar spondylodiscitis, which emerged as a complication after surgical intervention in the lumbar region, were investigated.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:C-reaktif protein · ekonomik maliyet · iyatrojenik
Abstract
Objective: In this study, the economic cost, diagnostic and prognostic laboratory markers of lumbar spondylodiscitis, which emerged as a complication after surgical intervention in the lumbar region, were investigated.
Özet
Amaç: Bu çalışmada lomber bölgeye cerrahi müdahale sonrası komplikasyon olarak ortaya çıkan lomber spondilodiskitte ekonomik maliyet ile tanısal ve prognostik laboratuvar belirteçleri araştırıldı.
YÜKSEL, U., ÖĞDEN, M., AKKAYA, S., KISA, Ü., BAKAR, B., ÖZVEREN, M. F. (2020). EECONOMIC COST, DIAGNOSTIC AND PROGNOSTIC MARKERS IN IATROGENIC LUMBAR SPONDYLODISCITIS. Kırıkkale Üniversitesi Tıp Fakültesi Dergisi, Cilt: 22 - Sayı: 3, 341–347. https://ajindex.com/articles/209447
Czigléczki G, Benkő Z, Misik F, Banczerowski P. Incidence, morbidity, and surgical outcomes of complex spinal inflammatory syndromes in adults. World Neurosurg. 2017;107:63-8. Doi:10.1016/j.wneu.2017.07.096
Pola E, Taccari F, Autore G, Giovannenze F, Pambianco V, Cauda R et al. Multidisciplinary management of pyogenic spondylodiscitis: epidemiological and clinical features, prognostic factors and long-term outcomes in 207 patients. Eur Spine J. 2018;27(Suppl 2):229-36
Wang X, Tao H, Zhu Y, Lu X, Hu X. Management of postoperative spondylodiscitis with and without internal fixation. Turk Neurosurg. 2015;25(4):513-8
Bernard L, Dinh A, Ghout I, Simo D, Zeller V, Issartel B et al and Duration of Treatment for Spondylodiscitis (DTS) study group. Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial. Lancet. 2015;385(9971):875-82
Noh SH, Zhang HY, Lim HS, Song HJ, Yang KH. Decompression alone versus fusion for pyogenic spondylodiscitis. Spine J. 2017;17(8):1120-6
Tschugg A, Lener S, Hartmann S, Rietzler A, Neururer S, Thome C. Primary acquired spondylodiscitis shows a more severe course than spondylodiscitis following spine surgery: a single-center retrospective study of 159 cases. Neurosurg Rev. 2018;41(1):141-7
Tschugg A, Hartmann S, Lener S, Rietzler A, Sabrina N, Thome C. Minimally invasive spine surgery in lumbar spondylodiscitis: a retrospective single-center analysis of 67 cases. Eur Spine J. 2017;26(12):3141-6
Sheikh AF, Khosravi AD, Goodarzi H, Nashibi R, Teimouri A, Motamedfar A et al. Pathogen identification in suspected cases of pyogenic spondylodiscitis. Front Cell Infect Microbiol. 2017;7:60. Doi:10.3389/fcimb.2017.00060.